The European League Against Rheumatism (EULAR)2011 May 24, 2011

EULAR 2011 aims to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. EULAR the primary platform for exchange of scientific and clinical information in Europe. It is also a renowned forum for interaction between medical doctors, scientists, people with arthritis/rheumatism, health professionals and representatives of the pharmaceutical industry worldwide. The scientific program at the congress covers a wide range of topics on clinical innovations, clinical, translational and basic science. Meetings set up by associations of people with arthritis/rheumatism, health professionals and the health care industry complement the program. The poster sessions, offering lively interaction between presenters and participants, are regarded by many as the heart of the congress.

Jichao Sun, Senior Director of Clinical Development, will speak on the topic "Results of a Randomized, Placebo-Controlled, Phase 2a Study of Sifalimumab, an Anti-Interferon-α Monoclonal Antibody, Administered Subcutaneously in Subjects with Systemic Lupus Erythematosu."

Ryan Criste will speak on the topics of "Intravenous Pharmacokinetics and Immunogenicity of Sifalimumab, an Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus" and "Pharmacokinetics and Immunogenicity of Sifalimumab, an Anti-Interferon-α Monoclonal Antibody, Administered Subcutaneously in Systemic Lupus Erythematosus."

Wei Zhu will speak on the topic of "mRNA and microRNA expression profiles in patients with inclusion body myositis, polymyositis and dermatomyositis."

MedImmune is a sponsor.